Home > Healthcare > Analytical Instruments > Analytical Instrumentation Market

Analytical Instrumentation Market Trends

  • Report ID: GMI5961
  • Published Date: Jun 2023
  • Report Format: PDF

Analytical Instrumentation Market Trends

Technological advancements in analytical instrumentation have greatly influenced drug discovery and life science research. Technological advancements in automation, robotics, and miniaturization have revolutionized drug discovery, enabling researchers to rapidly test thousands or even millions of compounds. This has significantly accelerated the drug discovery process. Advances in mass spectrometry technology such as improved sensitivity, resolution, and data analysis algorithms have expanded its applications and enhanced its capabilities in the fields of proteomics, metabolomics, and drug metabolism studies. The integration of technological advancements in analytical instrumentation has also led to significant improvements in chromatographic techniques, making them more efficient, sensitive, and reliable.
 

The high-performance liquid chromatography (HPLC) systems have seen several technological advancements such as the development of smaller particle sizes for stationary phases, improved column designs, and more advanced detectors. These advancements have enhanced the resolution, sensitivity, and speed of HPLC analyses, allowing for better separation and detection of pharmaceutical compounds. Overall, technological advancements in analytical instrumentation have revolutionized pharmaceutical research by enhancing the capabilities of analytical techniques. These advancements have improved the efficiency, sensitivity, and accuracy of analyses, enabling researchers to make significant improvements in drug discovery, development, and quality control in the pharmaceutical & biotechnology industry.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Market size for analytical instrumentation was valued at around USD 51.7 billion in 2022 and will reach over USD 81.6 billion by 2032. The field of pharmaceutical & biotechnology is increasingly focused on personalized medicine, driving the demand for analytical instruments that can perform genomics, proteomics, metabolomics, and other molecular analyses at a high level of accuracy and speed.

The spectroscopy instruments segment share was valued at over USD 19.7 billion in 2022. This segmental share is attributable to the increasing complexity of drug molecules, stringent quality control regulations, and the demand for faster & more sensitive analysis methods.

U.S. dominated North America analytical instrumentation market in 2022 and will generate around USD 34 billion by 2032, owing to technological advancements, presence of leading players in the region, and increasing R&D spending by pharmaceutical companies & government research organizations.

Agilent Technologies Inc., Avantor, Inc., Bio-Rad Laboratories Inc., Bruker Corporation, F. Hoffmann-La Roche AG, Hitachi High-Technologies Corporation, and Illumina, Inc. among others.

Analytical Instrumentation Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 18
  • Tables & Figures: 463
  • Countries covered: 29
  • Pages: 180
 Download Free Sample